4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol has been researched along with Adenocarcinoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balbo, S; Hecht, SS; James-Yi, SA; Johnson, CS; Khariwala, SS; Kovi, RC; Le, CT; O'Sullivan, MG; Upadhyaya, P; Wang, M | 1 |
D'Agostino, J; Ding, X; Xie, F; Zhou, X | 1 |
Chase, GA; Dyer, AM; Gallagher, CJ; Hicks, AN; Lazarus, P; Muscat, JE; Richie, J; Zheng, Y | 1 |
3 other study(ies) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Adenocarcinoma
Article | Year |
---|---|
Carcinogenicity and DNA adduct formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F-344 rats.
Topics: Adenocarcinoma; Adenoma; Animals; Apoptosis; Carcinogens; Chromatography, High Pressure Liquid; DNA Adducts; DNA Damage; Humans; Lung Neoplasms; Male; Nitrosamines; Pancreatic Neoplasms; Prohibitins; Pyridines; Rats; Rats, Inbred F344; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism | 2014 |
Role of CYP2A5 in the bioactivation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Aryl Hydrocarbon Hydroxylases; Biotransformation; Cytochrome P-450 CYP2A6; Cytochrome P450 Family 2; Female; Lung; Lung Neoplasms; Mice; Mice, Knockout; Microsomes, Liver; Nitrosamines; Pyridines; Tissue Distribution | 2012 |
The UDP-glucuronosyltransferase 2B17 gene deletion polymorphism: sex-specific association with urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronidation phenotype and risk for lung cancer.
Topics: Adenocarcinoma; Biomarkers, Tumor; Case-Control Studies; Cross-Sectional Studies; Female; Florida; Gene Deletion; Genotype; Glucuronosyltransferase; Humans; Logistic Models; Lung Neoplasms; Male; New York; Nitrosamines; Phenotype; Pyridines; Risk; Smoking | 2007 |